May 20th is World Clinical Trials Day...Roche Korea Holds Commemorative Event
May 20, 2025
|
Clinical trials are scientific procedures to validate the efficacy and safety of new treatments, providing patients with better treatment options and driving advances in medical technology. In celebration of World Clinical Trials Day, countries around the world are reflecting on the meaning of clinical trials and thanking researchers for their dedication.
Roche Korea also held an in-house celebration on the 19th ahead of World Clinical Trials Day. This event was designed to publicize the importance of clinical trials and to commemorate the hard work of researchers, relevant government agencies such as the Ministry of Food and Drug Safety, and patients who participated in clinical trials.
Through this event, Roche Korea had a meaningful time to share the medical and social value of clinical trials with in-house executives and employees and shed light on the contributions of the PDG Korea department in charge of clinical practice. It conducted the 'Gallery Week: Clinical Trial A to Z' and was held to educate employees about the history of clinical trials contributing to medical advancements and patient care worldwide. In addition, we directly shared meaningful moments when members of the PDG Korea department shared the challenges they faced in the actual clinical field, the overcoming process, and the patients' treatment journey. In addition, time was also set up to thank the clinical trial researchers and the Korea Roche clinical trial team for their dedication and efforts.
Meanwhile, in Korea Roche, more than 14.5% of the total workforce is in charge of R&D. It is conducting clinical trials at 521 institutions in Korea, and as of May 2025, 1848 patients have been enrolled in 120 clinical trials and are participating in the study. In particular, Roche Korea is actively attracting clinical trials to Korea in line with the government's direction of targeting the world's third-largest country for clinical trials. Currently, Korea is positioned as a strategic hub as it is among the top seven countries in global clinical trials within the Roche Group, and domestic medical staff are actively participating in global research in various treatment areas such as cancer, immunity, infection, ophthalmology, and nervous system.
Ezat Azem, CEO of Roche Korea, said "Clinical trials are an important process that must go through to provide effective and safe new drugs for patients. This event was a meaningful time to point out the hard work of everyone who participated in the meaningful journey of clinical trials and to express their gratitude to patients and researchers"
This article was translated by Naver AI translator.
